Retrospective Data Review of ReCap Total Hip Resurfacing

This study has been withdrawn prior to enrollment.
(No further contact with the site)
Biomet U.K. Ltd.
Information provided by (Responsible Party):
Biomet, Inc. Identifier:
First received: September 23, 2008
Last updated: December 5, 2011
Last verified: November 2011
Retrospective Data Review on clinical outcomes and survivorship of ReCap Total Hip Resurfacing

Condition Intervention
Osteoarthritis of the Hip
Device: ReCap Total Hip Resurfacing

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Retrospective Data Review of ReCap Total Hip Resurfacing

Further study details as provided by Biomet, Inc.:

Primary Outcome Measures:
  • Survival rate [ Time Frame: 2 yr ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Harris Hip Score [ Time Frame: 2yr ] [ Designated as safety issue: No ]

Enrollment: 0
Study Start Date: April 2004
Study Completion Date: April 2010
Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1 Device: ReCap Total Hip Resurfacing
ReCap Total Hip Resurfacing


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients who received ReCap Total Hip Resurfacing


  • Patients received ReCap total hip resurfacing
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Biomet, Inc. Identifier: NCT00758329     History of Changes
Other Study ID Numbers: BMET UK 09 
Study First Received: September 23, 2008
Last Updated: December 5, 2011
Health Authority: United Kingdom: Medicines and Healthcare Products Regulatory Agency

Additional relevant MeSH terms:
Osteoarthritis, Hip
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases processed this record on February 10, 2016